留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

宫颈绒毛腺管状腺癌的临床病理

游燕 郭丽娜

游燕, 郭丽娜. 宫颈绒毛腺管状腺癌的临床病理[J]. 协和医学杂志, 2012, 3(1): 61-67. doi: 10.3969/j.issn.1674-9081.2012.01.014
引用本文: 游燕, 郭丽娜. 宫颈绒毛腺管状腺癌的临床病理[J]. 协和医学杂志, 2012, 3(1): 61-67. doi: 10.3969/j.issn.1674-9081.2012.01.014
Yan YOU, Li-na GUO. Clinicopathologic Features of Villoglandular Papillary Adenocarcinoma of the Uterine Cervix[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 61-67. doi: 10.3969/j.issn.1674-9081.2012.01.014
Citation: Yan YOU, Li-na GUO. Clinicopathologic Features of Villoglandular Papillary Adenocarcinoma of the Uterine Cervix[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 61-67. doi: 10.3969/j.issn.1674-9081.2012.01.014

宫颈绒毛腺管状腺癌的临床病理

doi: 10.3969/j.issn.1674-9081.2012.01.014
详细信息
    通讯作者:

    郭丽娜 电话:010-65295521, E-mail:luna0076@sina.com

  • 中图分类号: R73;R446.8

Clinicopathologic Features of Villoglandular Papillary Adenocarcinoma of the Uterine Cervix

More Information
  • 摘要:   目的  探讨宫颈绒毛腺管状腺癌的临床病理特征、诊断标准及预后。  方法  分析北京协和医院10例宫颈绒毛腺管状腺癌的临床病理表现, 临床资料包括年龄、症状、术前检查、国际妇产科联盟(International Federation of Gynecology Obstetrics, FIGO)分期、治疗方式及随访结果, 病理表现包括大体表现、颈管浸润程度、有无淋巴结转移及淋巴脉管内瘤栓、组织学分型、核异型性、核分裂及伴随病变。  结果  10例患者平均发病年龄为39岁; 8例FIGO分期Ib1, 1例IIa, 1例Ia1;手术方式为全子宫切除+盆腔淋巴结清扫术+双附件切除术/卵巢活检术; 术后平均随访29个月, 8例健康生存, 1例复发, 1例失访。大体观察, 5例呈息肉样或菜花状外生性肿物, 直径5~25 mm; 4例呈乳头状或细绒毛样粗糙区, 面积25 mm×14 mm至35 mm×20 mm; 1例术后转移病例表现为溃疡型肿物, 直径25 mm。镜下肿瘤浸润深度2~12 mm, 浸润宽度5~26 mm, 1例累及阴道后穹窿; 9例有轻-中度核异型性, 术后转移1例病例呈中-重度核异型性; 核分裂平均48个/10高倍视野(HPF); 9例伴有宫颈上皮内瘤变Ⅲ级(cervical intraepithelial neoplasia Ⅲ, CIN Ⅲ)和/或原位腺癌(adenocarcinoma in situ, ACIS), 2例同时伴有高分化黏液腺癌; 1例观察到宫颈壁内个别淋巴脉管内瘤栓。10例均未发现子宫体受累、盆腔淋巴结或卵巢转移。  结论  宫颈绒毛腺管状腺癌的预后整体较好。提示预后不良的病理指标除了宫颈管壁深层浸润、累及宫体、血管浸润、淋巴结转移外, 还包括肿瘤细胞重度异型性和/或合并其他恶性程度更高的肿瘤成分。
  • 图  1  肿瘤表面富于纤维间质的粗乳头结构(HE, ×40)

    图  2  肿瘤表面具有纤维血管轴心的细乳头结构, 间质内见炎细胞浸润, 被覆假复层柱状上皮有轻-中度异型性(HE, ×100)

    图  3  高度异型性的乳头被覆上皮, 核分裂象(箭头)易见(HE, ×200)

    图  4  宫颈绒毛腺管状腺癌合并宫颈上皮内瘤变Ⅲ级(HE, ×40)

    图  5  宫颈绒毛腺管状腺癌合并宫颈原位腺癌(HE, ×40)

    表  1  宫颈绒毛腺管状腺癌的术前诊断

    表  2  宫颈绒毛腺管状腺癌的术前诊断

    表  3  宫颈绒毛腺管状腺癌的病理表现

  • [1] Jones MW, Silverberg SG, Kurman RJ. Well-differentiated villoglandular adenocarcinoma of the uterine cervix:a clinicopathological study of 24 cases[J]. Int J Gynecol Pathol, 1993, 12:1-7. doi:  10.1097/00004347-199301000-00001
    [2] Jones MW, Kounelis S, Papadaki H, et al. Well-differentiated villoglandular adenocarcinoma of the uterine cervix:oncogene/tumor suppressor gene alterations and human papillomavirus genotyping[J]. Int J Gynecol Pathol, 2000, 19:110-117. doi:  10.1097/00004347-200004000-00003
    [3] An HJ, Kim KR, Kim IS, et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma:a population-based study[J]. Mod Pathol, 2005, 18:528-534. doi:  10.1038/modpathol.3800316
    [4] Heatley MK. Villoglandular adenocarcinoma of the uterine cervix-a systematic review of the literature[J]. Histopathology, 2007, 51:268-269. doi:  10.1111/j.1365-2559.2007.02759.x
    [5] Alfsen GC, Reed W, Abeler VM. Reproducibility of classification in non-squamous cell carcinomas of the uterine cervix[J]. Gynecol Oncol, 2003, 90:282-289. doi:  10.1016/S0090-8258(03)00280-4
    [6] Young RH, Scully RE. Villoglandular papillary adenocarcinoma of the uterine cervix. a clinicopathologic analysis of 13 cases[J]. Cancer, 1989, 63:1773-1779. doi:  10.1002/1097-0142%2819900501%2963%3A9%3C1773%3A%3AAID-CNCR2820630920%3E3.0.CO%3B2-J
    [7] Utsugi K, Shimizu Y, Akiyama F, et al. Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix[J]. Gynecol Oncol, 2004, 92:64-70. doi:  10.1016/j.ygyno.2003.10.020
    [8] Rubesa-Mihaljević R, Vrdoljak-Mozetić D, Ostojić DV, et al. Villoglandular papillary adenocarcinoma of the uterine cervix with aggressive clinical course-a case report[J]. Coll Antropol, 2010, 34:291-294. http://www.ncbi.nlm.nih.gov/pubmed/20437645
    [9] Young RH, Clement PB. Endocervical adenocarcinoma and its variants:their morphology and differential diagnosis[J]. Histopathology, 2002, 41:185-207. doi:  10.1046/j.1365-2559.2002.01462.x
    [10] Fadare O, Zheng W. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix with a focal highgrade component:is there a need for reassessment?[J]. Virchows Arch, 2005, 447:883-887. doi:  10.1007/s00428-005-0030-3
    [11] Bouman A, Oosterhuis GJ, Naudin ten Cate L, et al. Villoglandular papillary adenocarcinoma of the cervix. Beware of a wolf in sheep's clothing[J]. Eur J Obstet Gynecol Reprod Biol, 1999, 87:183-189. doi:  10.1016/S0301-2115(99)00106-2
    [12] Takai N, Hayashita C, Nakamura S, et al. A case of villoglandular papillary adenocarcinoma of the uterine cervix diagnosed during early pregnancy followed by successful term delivery[J]. Case Report Med, 2010, 314547. http://europepmc.org/articles/PMC2892664
    [13] Khunamornpong S, Maleemonkol S, Siriaunkgul S, et al. Well-Differentiated villoglandular adenocarcinoma of the uterine cervix:a report of 15 cases including two with lymph node metastasis[J]. J Med Assoc Thai, 2001, 84:882-888. https://www.sciencedirect.com/science/article/pii/S187395981100010X
    [14] Alfsen GC, Kristensen GB, Skovlund E, et al. Histologic subtype has a minor importance for overall survival in patients with adenocarcinoma of the uterine cervix[J]. Cancer, 2001, 92:2471-2483. doi:  10.1002/1097-0142(20011101)92:9<2471::AID-CNCR1597>3.0.CO;2-K
    [15] Kaku T, Kamura T, Shigematsu T, et al. Adenocarcinoma of the uterine cervix with predominantly villoglandular papillary growth pattern[J]. Gynecol Oncol, 1999, 64:147-152. http://www.sciencedirect.com/science/article/pii/S0090825896945394
    [16] Macdonald RD, Kirwan J, Hayat K, et al. Villoglandular adenocarcinoma of the cervix:clarity is needed on the histological definition for this difficult diagnosis[J]. Gynecol Oncol, 2006, 100:192-194. doi:  10.1016/j.ygyno.2005.07.133
  • 加载中
图(5) / 表(3)
计量
  • 文章访问数:  218
  • HTML全文浏览量:  32
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2011-10-31
  • 刊出日期:  2012-01-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!